Filing Details
- Accession Number:
- 0001209191-15-055178
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2015-06-19 19:04:35
- Reporting Period:
- 2015-06-18
- Filing Date:
- 2015-06-19
- Accepted Time:
- 2015-06-19 18:04:35
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1368148 | Athersys Inc / New | ATHX | Pharmaceutical Preparations (2834) | 204864095 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1402604 | Gil Bokkelen Van | 3201 Carnegie Avenue Cleveland OH 44115 | Chmn & Chief Executive Officer | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2014-06-18 | 11,035 | $1.21 | 854,171 | No | 4 | F | Direct | |
| Common Stock | Disposition | 2014-06-18 | 4,750 | $1.23 | 849,421 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2014-06-19 | 4,750 | $1.23 | 844,671 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | F | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Footnotes
- Shares withheld from the quarterly vesting of a June 2013 restricted stock unit award related to the minimum tax withholding obligation.
- Shares sold pursuant to a predefined Rule 10b5-1 trading plan solely related to the tax obligation on the quarterly vesting of a June 2013 restricted stock unit award.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.21 to $1.26, inclusive, in accordance with a previously established Rule 10b5-1 predefined trading plan enacted solely related to the tax obligation.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.205 to $1.25, inclusive, in accordance with a previously established Rule 10b5-1 predefined trading plan enacted solely related to the tax obligation.
- Securities beneficially owned are comprised of: (1) 543,751 shares of common stock owned, (2) 231,680 restricted stock units awarded on June 20, 2013 related to the termination of 2005 incentive agreements that will vest ratably on a quarterly basis through June 18, 2016, and (3) restricted stock units awarded on an annual basis amounting to 69,240 that vest quarterly over a four-year period from grant date.
Billionaire Hedge Funds
